Literature DB >> 2339591

Myopathy with altered mitochondria due to a triosephosphate isomerase (TPI) deficiency.

A Bardosi1, S W Eber, M Hendrys, A Pekrun.   

Abstract

Morphological changes are shown in the muscle biopsy specimens of an 8-year-old girl who suffered from a triosephosphate isomerase (TPI) deficiency, resulting in a chronic, nonspherocytic, hemolytic anemia, mental retardation and neuromuscular impairment. The newly introduced enzyme histochemical reaction for TPI demonstrated a total lack of histochemically detectable enzyme activity, whereas biochemical analysis of muscle tissue revealed less than 10% of the normal enzyme activity. Electron microscopy showed a degenerative myopathy with an increase in the amount of intracellular glycogen. Additionally, mitochondrial changes within the muscle fibers were observed to be similar to those in mitochondrial myopathies. The disturbed balance between glycerin-aldehyde phosphate and dihydroxyacetone phosphate, due to the deficiency of the TPI enzyme, is interpreted as the biochemical background of an impaired electron transport across the mitochondrial membrane, resulting in the coexistence of an impaired glycolytic pathway and an impaired mitochondrial metabolism of muscle cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2339591     DOI: 10.1007/bf00308714

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

1.  HEREDITARY HEMOLYTIC ANEMIA WITH TRIOSEPHOSPHATE ISOMERASE DEFICIENCY.

Authors:  A S SCHNEIDER; W N VALENTINE; M HATTORI; H L HEINS
Journal:  N Engl J Med       Date:  1965-02-04       Impact factor: 91.245

2.  Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder.

Authors:  A Bardosi; W Creutzfeldt; S DiMauro; K Felgenhauer; R L Friede; H H Goebel; A Kohlschütter; G Mayer; G Rahlf; S Servidei
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

3.  Hereditary deficiency of phosphoglycerate kinase: a new variant in erythrocytes and leucocytes, not associated with haemolytic anaemia.

Authors:  W K Krietsch; H Krietsch; W Kaiser; M Dünnwald; G W Kuntz; J Duhm; T Bücher
Journal:  Eur J Clin Invest       Date:  1977-10       Impact factor: 4.686

4.  Ultrastructural and histochemical abnormalities of skeletal muscle in a patient with a new variant (type Homburg) of glucosephosphate isomerase (GPI) deficiency.

Authors:  A Bardosi; S W Eber; U Roessmann
Journal:  Clin Neuropathol       Date:  1985 Mar-Apr       Impact factor: 1.368

5.  Triosephosphate isomerase deficiency. A case report with neuropathological findings.

Authors:  S A Clay; N A Shore; B H Landing
Journal:  Am J Dis Child       Date:  1982-09

6.  Hereditary deficiency of lactate dehydrogenase M-subunit.

Authors:  T Kanno; K Sudo; I Takeuchi; S Kanda; N Honda; Y Nishimura; K Oyama
Journal:  Clin Chim Acta       Date:  1980-12-08       Impact factor: 3.786

7.  Triosephosphate isomerase deficiency: haemolytic anaemia, myopathy with altered mitochondria and mental retardation due to a new variant with accelerated enzyme catabolism and diminished specific activity.

Authors:  S W Eber; A Pekrun; A Bardosi; M Gahr; W K Krietsch; J Krüger; R Matthei; W Schröter
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

8.  Phosphoglycerate kinase deficiency: another cause of recurrent myoglobinuria.

Authors:  S DiMauro; M Dalakas; A F Miranda
Journal:  Ann Neurol       Date:  1983-01       Impact factor: 10.422

9.  The isolation and characterization of the multiple forms of human skeletal muscle triosephosphate isomerase.

Authors:  S W Eber; W K Krietsch
Journal:  Biochim Biophys Acta       Date:  1980-07-10

10.  Human muscle phosphoglycerate mutase deficiency: newly discovered metabolic myopathy.

Authors:  S DiMauro; A F Miranda; S Khan; K Gitlin; R Friedman
Journal:  Science       Date:  1981-06-12       Impact factor: 47.728

View more
  6 in total

1.  Drosophila model of human inherited triosephosphate isomerase deficiency glycolytic enzymopathy.

Authors:  Alicia M Celotto; Adam C Frank; Jacquelyn L Seigle; Michael J Palladino
Journal:  Genetics       Date:  2006-09-15       Impact factor: 4.562

2.  miR-1183 Is a Key Marker of Remodeling upon Stretch and Tachycardia in Human Myocardium.

Authors:  Natasa Djalinac; Ewald Kolesnik; Heinrich Maechler; Susanne Scheruebel-Posch; Brigitte Pelzmann; Peter P Rainer; Ines Foessl; Markus Wallner; Daniel Scherr; Akos Heinemann; Simon Sedej; Senka Ljubojevic-Holzer; Dirk von Lewinski; Egbert Bisping
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

3.  Triosephosphate isomerase deficiency: haemolytic anaemia, myopathy with altered mitochondria and mental retardation due to a new variant with accelerated enzyme catabolism and diminished specific activity.

Authors:  S W Eber; A Pekrun; A Bardosi; M Gahr; W K Krietsch; J Krüger; R Matthei; W Schröter
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

4.  Familial myopathy with elevated serum angiotensin-converting enzyme, creatine kinase and lactate dehydrogenase isoenzyme 5.

Authors:  T Henze; A Bardosi; H R Reichmann
Journal:  J Neurol       Date:  1991-08       Impact factor: 4.849

5.  Hereditary triosephosphate isomerase (TPI) deficiency: two severely affected brothers one with and one without neurological symptoms.

Authors:  S Hollán; H Fujii; A Hirono; K Hirono; H Karro; S Miwa; V Harsányi; E Gyódi; M Inselt-Kovács
Journal:  Hum Genet       Date:  1993-11       Impact factor: 4.132

6.  Human triosephosphate isomerase deficiency resulting from mutation of Phe-240.

Authors:  M L Chang; P J Artymiuk; X Wu; S Hollán; A Lammi; L E Maquat
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.